Two agents deliver knockout punches to Ewing sarcoma
When combined with an already FDA-approved chemotherapy, a novel agent developed by researchers at Georgetown Lombardi Comprehensive Cancer Center, appears to halt the ability of Ewing sarcoma to grow and progress.
Oct 3, 2017
0
40